Showing 1 - 7 results of 7 for search 'Max Topp', query time: 0.03s Refine Results
  1. 1
    The use of tafasitamab in diffuse large B-cell lymphoma

    The use of tafasitamab in diffuse large B-cell lymphoma by Johannes Düll, Max Topp, Gilles Salles

    Published 2021-07-01
    Get full text
    Article
  2. 2
    Immunological Aspects of Candida and Aspergillus Systemic Fungal Infections

    Immunological Aspects of Candida and Aspergillus Systemic Fungal Infections by Christoph Mueller-Loebnitz, Helmut Ostermann, Anke Franzke, Juergen Loeffler, Lutz Uharek, Max Topp, Hermann Einsele

    Published 2013-01-01
    Get full text
    Article
  3. 3
    Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies

    Neuropsychiatric manifestations following chimeric antigen receptor T cell therapy for cancer: a systematic review of clinical outcomes and management strategies by Max Topp, Michael Hudecek, Hermann Einsele, Imad Maatouk, Leo Rasche, Johannes Duell, Anna Fleischer, Sophia Kurth, Patrick-Pascal Strunz, Julia Mersi, Carmen Sanges

    Published 2024-12-01
    Get full text
    Article
  4. 4
    Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies

    Safety of AFM11 in the treatment of patients with B-cell malignancies: findings from two phase 1 studies by Max Topp, Monika Dlugosz-Danecka, Aleksander B. Skotnicki, Galina Salogub, Andreas Viardot, Andreas K. Klein, Georg Hess, Christian S. Michel, Sebastian Grosicki, Alex Gural, Sylvia E. Schwarz, Kerstin Pietzko, Ulrike Gärtner, András Strassz, Leila Alland, Jiri Mayer

    Published 2023-01-01
    Get full text
    Article
  5. 5
    Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults

    Approaches for bridging therapy prior to chimeric antigen receptor T cells for relapsed/refractory acute lymphoblastic B-lineage leukaemia in children and young adults by Tobias Feuchtinger, Peter Bader, Marion Subklewe, Maike Breidenbach, Semjon Willier, Markus Metzler, Nicola Gökbuget, Julia Hauer, Fabian Müller, Paul-Gerhardt Schlegel, Michael Frühwald, Christoph Schmid, Anja Troeger, Claudia Baldus, Roland Meisel, Annette Künkele, Max Topp, Jean-Pierre Bourquin, Gunnar Cario, Arend von Stackelberg, Christina Peters

    Published 2024-02-01
    Get full text
    Article
  6. 6
    CcpA- and Shm2-Pulsed Myeloid Dendritic Cells Induce T-Cell Activation and Enhance the Neutrophilic Oxidative Burst Response to Aspergillus fumigatus

    CcpA- and Shm2-Pulsed Myeloid Dendritic Cells Induce T-Cell Activation and Enhance the Neutrophilic Oxidative Burst Response to Aspergillus fumigatus by Lukas Page, Julia Wallstabe, Julia Wallstabe, Jasmin Lother, Jasmin Lother, Maximilian Bauser, Olaf Kniemeyer, Olaf Kniemeyer, Lea Strobel, Vera Voltersen, Vera Voltersen, Janka Teutschbein, Janka Teutschbein, Peter Hortschansky, Peter Hortschansky, Charles Oliver Morton, Axel A. Brakhage, Axel A. Brakhage, Max Topp, Hermann Einsele, Sebastian Wurster, Juergen Loeffler

    Published 2021-05-01
    Get full text
    Article
  7. 7
    EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma

    EASIX-guided risk stratification for complications and outcome after CAR T-cell therapy with ide-cel in relapsed/refractory multiple myeloma by Xiang Zhou, Patrick Costello, Anita Schmitt, Carsten Müller-Tidow, Peter Dreger, Michael Schmitt, Max Topp, Hartmut Goldschmidt, Hermann Einsele, Nikhil C Munshi, Marc S Raab, Joseph Kauer, Thomas Hielscher, Niels Weinhold, Mirco J Friedrich, Sandra Sauer, Leo Rasche, Thomas Luft, Jan H Frenking, Vivien Wagner, Elias K Mai, Christian S Michel, Marina Hajiyianni, Iris Breitkreutz, Omar Nadeem, Adam S Sperling

    Published 2024-10-01
    Get full text
    Article

Search Tools: